Wam Global Ltd (WGB.AX) stock: key figures, P/E, revenue and dividend
Financials · Asset Management & Custody Banks · Australia · ISIN AU0000009649
Price
1.94 AUD
Market cap
695.31 m AUD
P/E (2026)
–
P/S (2026)
–
Dividend yield
6.80 %
Net margin
94.52 %
Return on equity (ROE)
-4.28 %
Return on assets (ROA)
-4.18 %
Wam Global Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 161.10 m AUD | -37.27 m AUD |
| Gross profit | 160.11 m AUD | -49.18 m AUD |
| Operating income | 147.62 m AUD | -50.32 m AUD |
| Net income | 103.34 m AUD | -35.23 m AUD |
| Diluted EPS – continuing operations | 0.29 AUD | -0.10 AUD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Wam Global Ltd
WAM Global Limited is a listed investment company launched and managed by Wilson Asset Management (International) Pty Limited. The firm invests in the public equity markets across the globe. It primarily invests in value stocks of companies. WAM Global Limited is based in Sydney, Australia.
More stocks
- OIL STATES INTERNATIONAL, INC (OIS)
- Tian Jin Global Magnetic Card Co Ltd (600800.SS)
- Yuilrobotics Co. Ltd. (388720.KQ)
- GLADSTONE COMMERCIAL CORP (GOOD)
- Zhejiang Natural Outdoor Goods Inc. (605080.SS)
- Thesis Gold Inc (TAU.V)
- Qingdao Kingking Applied Chemistry Co Ltd (002094.SZ)
- GYRE THERAPEUTICS, INC. (GYRE)
- Zhejiang Hengwei Battery Co. Ltd. (301222.SZ)
- Good Finance Securities Co Ltd (6021.TWO)
- Kofola CeskoSlovensko as (KOFOL.PR)
- Harbin Medisan Pharmaceutical Co Ltd (002900.SZ)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.